Amyotrophic Lateral Sclerosis - 319 Studies Found
| Completed |
: Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients? : Amyotrophic Lateral Sclerosis 11 : 2013-01-17 |
| Not yet recruiting |
: The Use of Airway Clearance Devices in ALS : Amyotrophic Lateral Sclerosis : 2016-02-04 :
|
| Not yet recruiting |
: Brown Adipose Tissue in ALS : Amyotrophic Lateral Sclerosis : 2017-05-09 :
|
| Completed |
: Safety and Biomarker Study of EPI-589 in Subjects With ALS : Amyotrophic Lateral Sclerosis : 2015-05-21 : Drug: EPI-589 An immediate release film-coated table at a 250 mg dosage strength. |
| Recruiting |
: "New Perspectives of Adaptation to NIV in ALS" : Amyotrophic Lateral Sclerosis (ALS) : 2015-08-28 : Other: Adaptation and training to Non Invasive Ventilation (NIV) Each person recruited after a respirato |
| Completed |
: Safety Extension Study of TRO19622 in ALS : Amyotrophic Lateral Sclerosis : 2011-01-26 : Drug: TRO19622 2 capsules of TRO19622 (330mg) once a day with the noon meal as add-on therapy to riluzol |
| Active, not recruiting |
: Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis : Amyotrophic Lateral Sclerosis (ALS) : 2012-05-22 : Device: NeuRx Diaphragm Pacing System (DPS) The NeuRx DPS is a percutaneous, intramuscular, diaphragm st |
| Completed |
: ALS Treatment Extension Study : Amyotrophic Lateral Sclerosis : 2017-04-28 : Drug: Cu(II)ATSM copper-containing synthetic small molecule |
| Completed |
: CNS10-NPC-GDNF for the Treatment of ALS : Amyotrophic Lateral Sclerosis : 2016-10-20 :
|
| Completed |
: SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) : Familial Amyotrophic Lateral Sclerosis : 2009-12-17 : Drug: Pyrimethamine Open Label, dose escalating, Oth |